نتایج جستجو برای: early virologic response

تعداد نتایج: 1595197  

2005
Romulus Breban Sally Blower

present a novel hypothesis that could explain virologic failure to STI and provides new insights of great clinical relevance. We analyze a classic mathematical model of HIV within-host viral dynamics and find that nonlinear parametric resonance occurs when STI are added to the model; resonance is observed as virologic failure. We use the model to simulate clinical trial data and to calculate pa...

2014
Juan J. Calva Juan Sierra-Madero Luis E. Soto-Ramírez Pedro Aguilar-Salinas

BACKGROUND Designing optimal antiretroviral (ARV) salvage regimens for multiclass drug-resistant, human immunodeficiency virus (HIV)-infected patients demands specific clinical skills. Our aim was to assess the virologic and immunologic effects of the treatment recommendations drafted by a peer advisory board to physicians caring for heavily ARV-experienced patients. METHODS We conducted a na...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999
W Tantisiriwat P Tebas D B Clifford W G Powderly C J Fichtenbaum

Recent reports suggest that human immunodeficiency virus (HIV)-associated progressive multifocal leukoencephalopathy (PML) may improve with highly active antiretroviral therapy (HAART). We observed three patients who developed PML while receiving HAART. All patients received HAART for 4-11 months and had low plasma levels of HIV-1 RNA before the onset of symptoms of PML. Antiretroviral therapy ...

Journal: :The New England journal of medicine 2015
Graham R Foster Nezam Afdhal Stuart K Roberts Norbert Bräu Edward J Gane Stephen Pianko Eric Lawitz Alex Thompson Mitchell L Shiffman Curtis Cooper William J Towner Brian Conway Peter Ruane Marc Bourlière Tarik Asselah Thomas Berg Stefan Zeuzem William Rosenberg Kosh Agarwal Catherine A M Stedman Hongmei Mo Hadas Dvory-Sobol Lingling Han Jing Wang John McNally Anu Osinusi Diana M Brainard John G McHutchison Francesco Mazzotta Tram T Tran Stuart C Gordon Keyur Patel Nancy Reau Alessandra Mangia Mark Sulkowski

BACKGROUND In phase 2 trials, treatment with the combination of the nucleotide polymerase inhibitor sofosbuvir and the NS5A inhibitor velpatasvir resulted in high rates of sustained virologic response in patients chronically infected with hepatitis C virus (HCV) genotype 2 or 3. METHODS We conducted two randomized, phase 3, open-label studies involving patients who had received previous treat...

Journal: :The New England journal of medicine 2014
Fred Poordad Christophe Hezode Roger Trinh Kris V Kowdley Stefan Zeuzem Kosh Agarwal Mitchell L Shiffman Heiner Wedemeyer Thomas Berg Eric M Yoshida Xavier Forns Sandra S Lovell Barbara Da Silva-Tillmann Christine A Collins Andrew L Campbell Thomas Podsadecki Barry Bernstein

BACKGROUND Interferon-containing regimens for the treatment of hepatitis C virus (HCV) infection are associated with increased toxic effects in patients who also have cirrhosis. We evaluated the interferon-free combination of the protease inhibitor ABT-450 with ritonavir (ABT-450/r), the NS5A inhibitor ombitasvir (ABT-267), the nonnucleoside polymerase inhibitor dasabuvir (ABT-333), and ribavir...

2015
Bernhard Kerschberger Andrew M Boulle Katharina Kranzer Katherine Hilderbrand Michael Schomaker David Coetzee Eric Goemaere Gilles Van Cutsem

INTRODUCTION Routine viral load (VL) monitoring is utilized to assess antiretroviral therapy (ART) adherence and virologic failure, and it is currently scaled-up in many resource-constrained settings. The first routine VL is recommended as late as six months after ART initiation for early detection of sub-optimal adherence. We aimed to assess the optimal timing of first VL measurement after ini...

Journal: :Journal of acquired immune deficiency syndromes 2002
Nancy S Shulman Michael D Hughes Mark A Winters Robert W Shafer Andrew R Zolopa Nicholas S Hellmann Michael Bates Jeannette M Whitcomb David A Katzenstein

To identify the level of phenotypic susceptibility for stavudine (d4T) that is associated with a diminished virologic response to d4T therapy, phenotyping was performed on archived baseline HIV isolates from 26 subjects who received d4T monotherapy in AIDS Clinical Trials Group (ACTG) 302 who had received >3 years of prior zidovudine (ZDV) monotherapy. Seven of 26 subjects achieved a virologic ...

Journal: :The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2006
Necati Yenice Ozgür Mehtap Mübeccel Gümrah Nurten Arican

BACKGROUND/AIMS We aimed to compare viral responses to pegylated interferon 2a plus ribavirin with pegylated interferon alpha 2b plus ribavirin. METHODS Patients with the following characteristics were included: anti HCV(+); normal and/or elevated serum transaminase levels; positive HCV RNA by quantitative PCR; and at least stage 1 fibrosis according to Knodell Scoring System on liver biopsy....

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید